Treatment of primary eosinophilic colitis using immunoglobulin/histamine complex-Reference-Cited by-同舟云学术

Treatment of primary eosinophilic colitis using immunoglobulin/histamine complex

Published:2023-01 Issue:1 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Kim Hyuk Soon¹²,Noh Geunwoong³^ORCID

Affiliation:

1. Department of Biomedical Sciences, College of Natural Science The Graduate School of Dong‐A University Busan Korea

2. Department of Health Sciences The Graduate School of Dong‐A University Busan Korea

3. Department of Allergy and Clinical Immunology Cheju Halla General Hospital Jeju‐si Korea

Abstract

AbstractPrimary eosinophilic colitis (PEC) is a primary eosinophilic gastrointestinal disorder, and immunoglobulin/histamine complex (IHC) may be an effective therapeutic for PEC. IHC has a nonallergen‐specific antinociceptive effect in the treatment of histamine‐mediated pain.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.6885

Reference40 articles.

1. Eosinophilic colitis: epidemiology, clinical features, and current management

2. Benefit of ketotifen in patients with eosinophilic gastroenteritis

3. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders

4. Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020

5. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real‐life data

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases;International Journal of Molecular Sciences;2023-10-13